Almirall has entered a drug discovery collaboration with CrystalO to [...]

Kupando has dosed the first patient in a Phase 1 [...]

BlueWind Medical has received FDA 510(k) clearance for Revi Extend, [...]

Obsidian Therapeutics has enrolled the first patient in the registration-enabling [...]

AC Immune has outlined a series of clinical milestones expected [...]

ABLi Therapeutics has reported coordinated changes across 11 biomarkers linked [...]

A new AI model has generated patient-specific radiation dose-rate maps [...]

Boehringer Ingelheim’s Jascayd has received European marketing authorisation for idiopathic [...]

The National Health Council has launched a Detroit pilot campaign [...]

Aravax’s PVX108 has received FDA Fast Track designation as the [...]